Article
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis
2024-03-03
Abstract excerpt
Deficiencies in coagulation factor VIII (FVIII, F8) result in the bleeding disorder hemophilia A. An emerging novel therapeutic strategy for bleeding disorders is to enhance hemostasis by limiting natural anticoagulants, such as antithrombin (AT3). To study pro/anticoagulant hemostatic balance in an in vivo model, we used genome editing to create null alleles for f8 and von Willebrand factor (vwf) in zebrafish, a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 66a5b836-67c7-582f-9783-777ad9fcaa39
- DOI
- 10.1101/2024.02.28.582609
